2009Journal of Jianghan UniversityRequires access

Diagnosis Value of Combined Detection of Tumor Markers in Lung Cancer

Chenghong Li

Open publisher page 0 citations

Abstract

Objective:To evaluate the clinical diagnosis value of combined detection of serum CEA、CYFRA21-1、and NSE in patients with lung cancer. Methods:Serum CEA、CYFRA21-1、 and NSE levels were determined by electro-chemiluminescence immunoassay in 30 patients with lung cancer,30 patients with benign pulmonary diseases. Results:The serum levels of CEA、 CYFRA21-1、and NSE in patients with lung cancer were significantly higher than those with benign lung diseases(P 0.01). The positive rate of combined detection of serum CEA、CYFRA21-1、 and NSE in patients with lung cancer were significantly higher than that of serum CEA、CYFRA21-1、 and NSE levels ,separately. Conclusion:Combined determination of serum levels of CEA、 CYFR21-1、and NSE in lung cancers is helpful to improving the sensitivity and specificity in early diagnosis.

About this research paper

What this paper is about

Objective:To evaluate the clinical diagnosis value of combined detection of serum CEA、CYFRA21-1、and NSE in patients with lung cancer. Methods:Serum CEA、CYFRA21-1、 and NSE levels were determined by electro-chemiluminescence immunoassay in 30 patients with lung cancer,30 patients with benign pulmonary diseases. Results:The serum levels of CEA、 CYFRA21-1、and NSE in patients with lung cancer were significantly higher than those with benign lung diseases(P 0.01). The positive rate of combined detection of serum CEA、CYFRA21-1、 and NSE in patients with lung cancer were significantly higher than that of serum CEA、CYFRA21-1、 and NSE levels ,separately. Conclusion:Combined determination of serum levels of CEA、 CYFR21-1、and NSE in lung cancers is helpful to improving the sensitivity and specificity in early diagnosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the clinical diagnosis value of combined detection of serum CEA、CYFRA21-1、and NSE in patients with lung cancer. Methods:Serum CEA、CYFRA21-1、 and NSE levels were determined by electro-chemiluminescence immunoassay in 30 patients with lung cancer,30 patients with benign pulmonary diseases. Results:The serum levels of CEA、 CYFRA21-1、and NSE in patients with lung cancer were significantly higher than those with benign lung diseases(P 0.01). The positive rate of combined detection of serum CEA、CYFRA21-1、 and NSE in patients with lung cancer were significantly higher than that of serum CEA、CYFRA21-1、 and NSE levels ,separately. Conclusion:Combined determination of serum levels of CEA、 CYFR21-1、and NSE in lung cancers is helpful to improving the sensitivity and specificity in early diagnosis.

Key concepts: Lung cancer, Medicine, Internal medicine, Lung, Tumor marker, Immunoassay, Chemiluminescent immunoassay, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Diagnosis Value of Combined Detection of Tumor Markers in Lung Cancer — Research Paper | ScholarLens